Integrative Clinical and DNA Methylation Analyses in a Population-Based Cohort Identifies CDH17 and LRP2 as Risk Recurrence Factors in Stage II Colon Cancer

SIMPLE SUMMARY: Stage II colon cancer, although manageable by surgical resection with or without adjuvant chemotherapy, still accounts for 16% of colorectal cancer deaths. Prognostic biomarkers are keys to the risk stratification of patients and the decision to recommend adjuvant chemotherapy, but t...

Descripción completa

Detalles Bibliográficos
Autores principales: Tournier, Benjamin, Aucagne, Romain, Truntzer, Caroline, Fournier, Cyril, Ghiringhelli, François, Chapusot, Caroline, Martin, Laurent, Bouvier, Anne Marie, Manfredi, Sylvain, Jooste, Valérie, Callanan, Mary B., Lepage, Côme
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817957/
https://www.ncbi.nlm.nih.gov/pubmed/36612154
http://dx.doi.org/10.3390/cancers15010158

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817957/
https://www.ncbi.nlm.nih.gov/pubmed/36612154
http://dx.doi.org/10.3390/cancers15010158

Ejemplares similares